This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Haoyuan Medchemexpress Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Bao Fu Zheng
Introduction
Bao Fu Zheng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of camptothecin derivatives. His work is characterized by innovative methods that enhance the efficiency and cost-effectiveness of pharmaceutical production.
Latest Patents
Bao Fu Zheng holds a patent for an "Intermediate for synthesizing camptothecin derivative, preparation method therefor, and use thereof." This patent describes an intermediate compound A that can be synthesized from 3-fluoro-4-methylaniline through a series of reactions including acylation, bromination, and cross-coupling. The intermediate A is crucial for preparing intermediate B, which is further used to produce exatecan mesylate. The process is notable for its low-cost starting materials, moderate reaction conditions, and high yield, making it suitable for industrial production.
Career Highlights
Bao Fu Zheng is currently associated with Shanghai Haoyuan Medchemexpress Co., Ltd. His work at this company has allowed him to focus on the development of innovative chemical processes that have practical applications in the pharmaceutical industry. His expertise in synthetic methods has positioned him as a valuable asset in his field.
Collaborations
Bao Fu Zheng has collaborated with several professionals in his field, including Zhi Guo Zhou and Tao Ma. These collaborations have likely contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
In summary, Bao Fu Zheng is a distinguished inventor whose work in synthesizing camptothecin derivatives has significant implications for the pharmaceutical industry. His innovative approaches and successful patent demonstrate his commitment to advancing medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile